Dexamethasone suppression test: development of a method for simultaneous determination of cortisol and dexamethasone in human plasma by liquid chromatography/tandem mass spectrometry

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of Clinical Biochemistry

• Publication date

  2012-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1258/acb.2011.011004PMID 22247524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of Acute Relapses in Multiple Sclerosis

  2012cited by this paper
• The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

  2008cited by this paper
• Pitfalls in the diagnosis of Cushing's syndrome.

  2007cited by this paper
• Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays

  2007cited by this paper
• An overview of glucocorticoid anti-inflammatory actions

  2005cited by this paper
• Determination of the glucocorticoids prednisone, prednisolone, dexamethasone, and cortisol in human serum using liquid chromatography coupled to tandem mass spectrometry.

  2004cited by this paper
• Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids.

  2004cited by this paper
• A LIQUID CHROMATOGRAPHIC-TANDEM MASS SPECTROMETRIC METHOD FOR THE QUANTITATIVE ANALYSIS OF DEXAMETHASONE IN HUMAN PLASMA

  2002cited by this paper
• Treatment of acute relapses in multiple sclerosis at home with oral dexamethasone: a pilot study.

  1999cited by this paper
• Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects.

  1997cited by this paper
• Steroids and depression.

  1991cited by this paper
• Dexamethasone Concentrations and the Dexamethasone Suppression Test in Psychiatric Disorders

  1986cited by this paper
• Basic and Clinical Endocrinology.

  1982cited by this paper
• DEXAMETHASONE SUPPRESSION TESTS: USEFULNESS OF SIMULTANEOUS MEASUREMENT OF PLASMA CORTISOL AND DEXAMETHASONE

  1982cited by this paper

• Is evaluation of cortisol after dexamethasone suppression test enough? Analysis of steroid profile after dexamethasone suppression test using tandem mass spectrometry

  2025cites this paper
• Rapid Mental Stress Evaluation Based on Non-Invasive, Wearable Cortisol Detection with the Self-Assembly of Nanomagnetic Beads

  2025cites this paper
• Sensitive and rapid quantitation of dexamethasone in human plasma using liquid chromatography coupled with triple quadrupole mass spectrometer

  2023cites this paper
• The use of glucocorticoids in the treatment of cerebral edema for glioma tumour patients: Pro and Contra

  2023cites this paper
• Cortisol: Analytical and clinical determinants.

  2023cites this paper
• Novel Isotope Dilution High-Performance Liquid Chromatography Quadrupole–Linear Ion Trap Tandem Mass Spectrometry Method for the Determination of Five Steroid Hormones in Human Serum

  2023cites this paper
• Effect of autologous bone marrow derived mesenchymal stem cells in treatment of rheumatoid arthritis.

  2023cites this paper
• Simultaneous electrochemical investigation and detection of two glucocorticoids; interactions with human growth hormone, somatropin

  2022cites this paper
• Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome.

  2022cites this paper
• Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.

  2021cites this paper
• A multidisciplinary approach to the management of adrenal incidentaloma

  2021cites this paper
• Development and validation of a combined liquid chromatography tandem-mass spectrometry assay for the quantification of aprepitant and dexamethasone in human plasma to support pharmacokinetic studies in pediatric patients.

  2021cites this paper
• Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?

  2020cites this paper
• ANNALS EXPRESS: Retrospective analysis of repeated dexamethasone suppression tests - the added value of measuring dexamethasone.

  2019cites this paper
• Autonomous cortisol secretion in adrenal incidentalomas

  2019cites this paper
• Cushing’s Syndrome and Hypothalamic–Pituitary–Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy

  2018cites this paper
• A Validated Reversed Phase HPLC Assay for the Determination of Dexamethasone in Human Plasma

  2018cites this paper
• Development of a rapid liquid chromatography tandem mass spectrometry method for the quantitation of serum dexamethasone and its clinical verification

  2018cites this paper
• In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry.

  2017cites this paper
• Influence of sex, body mass index and age on the results of the 2-mg overnight dexamethasone suppression test

  2017cites this paper
• Der Einfluss von Geschlecht, Body-Mass-Index und Alter auf das Ergebnis des 2 mg Dexamethason-Kurzzeit-Suppressionstestes

  2017cites this paper
• Endogenous glucocorticoid analysis by liquid chromatography-tandem mass spectrometry in routine clinical laboratories.

  2016cites this paper
• The relationship between 63days of 24-h urinary free cortisol and hair cortisol levels in 10 healthy individuals.

  2016cites this paper
• Development of a Method for Determination of Dexamethasone (DEX) Concentrations in Human Plasma by Ultra Performance Liquid Chromatography / Photo Diode Array Detector (UPLC/PDA)

  2015cites this paper
• Pros and Cons of the Tuberculosis Drugome Approach – An Empirical Analysis

  2014cites this paper
• LC–MS/MS in the routine clinical laboratory: has its time come?

  2014cites this paper
• A validated method for measurement of serum total, serum free, and salivary cortisol, using high-performance liquid chromatography coupled with high-resolutionESI-TOF mass spectrometry

  2014cites this paper
• The prognostic value of cortisol measured by liquid chromatography coupled mass spectrometry in critically ill patients

  2014cites this paper
• Mass spectrometry for steroids

  2014cites this paper
• The use of mass spectrometry to improve the diagnosis and the management of the HPA axis

  2013cites this paper
• Multisteroid LC–MS/MS assay for glucocorticoids and androgens and its application in Addison's disease

  2013cites this paper